Jpmorgan Chase & Co »

Sarepta Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $275M 2.2M 124.89
2024-06-30 $291M 1.8M 158.00
2024-03-31 $237M 1.8M 129.46
2023-12-31 $126M 1.3M 96.43
2023-09-30 $559M 4.6M 121.22
2023-06-30 $505M 4.4M 114.67
2023-03-31 $365M 3.7M 100.00
2022-12-31 $162M 1.2M 129.93
2022-06-30 $77M 1.0M 74.77
2022-03-31 $85M 1.1M 77.80
2021-12-31 $95M 1.0M 90.28
2021-03-31 $56M 754k 74.70
2020-12-31 $129M 755k 170.45
2020-09-30 $162M 1.1M 143.79
2020-06-30 $254M 1.6M 161.02
2020-03-31 $112M 1.1M 97.86
2019-12-31 $121M 937k 129.16
2019-09-30 $7.8M 104k 75.50
2019-06-30 $13M 98k 129.51
2019-03-31 $26M 214k 119.76
2018-12-31 $22M 205k 108.61
2018-09-30 $14M 86k 161.51
2018-06-30 $27M 201k 132.18
2018-03-31 $53M 709k 74.09
2017-12-31 $24M 435k 55.65
2017-06-30 $9.3M 276k 33.71
2017-03-31 $4.8M 162k 29.60
2016-12-31 $1.7M 64k 27.44
2016-09-30 $4.2M 69k 61.42
2016-06-30 $11k 570 19.30
2016-03-31 $97k 4.9k 19.56
2015-12-31 $186k 4.5k 40.82
2013-09-30 $797k 17k 46.98
2013-06-30 $990k 26k 38.23